Neurodevelopmental Outcomes of Neonates Randomized to Morphine or Methadone for Treatment of Neonatal Abstinence Syndrome
Authors:
- 1 April 2020
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 219, 146-151.e1
Abstract
No abstract availableKeywords
Funding Information
- National Institute on Drug Abuse (R01DA032889)
This publication has 21 references indexed in Scilit:
- Rooming-In to Treat Neonatal Abstinence Syndrome: Improved Family-Centered Care at Lower CostPediatrics, 2016
- Congenital Central Hypoventilation SyndromeChest, 2016
- Neurodevelopmental Outcomes After Neonatal Surgery for Major Noncardiac AnomaliesPediatrics, 2016
- Cohort Analysis of a Pharmacokinetic-Modeled Methadone Weaning Optimization for Neonatal Abstinence SyndromeThe Journal of Pediatrics, 2015
- Prenatal Methamphetamine Exposure and Neonatal and Infant Neurobehavioral Outcome: Results from the IDEAL StudySubstance Abuse, 2014
- Neonatal neurobehavior effects following buprenorphine versus methadone exposureAddiction, 2012
- Children of Addicted WomenJournal of Addictive Diseases, 2010
- Neonatal Neurobehavior Predicts Medical and Behavioral OutcomePediatrics, 2010
- Management of neonatal abstinence syndrome: a national survey and review of practiceArchives of Disease in Childhood - Fetal and Neonatal Edition, 2009
- Test Review: Bayley, N. (2006). Bayley Scales of Infant and Toddler Development– Third Edition. San Antonio, TX: Harcourt AssessmentJournal of Psychoeducational Assessment, 2007